Sec Form 13G Filing - Malherbe Investments LLC filing for Enfusion, Inc. (ENFN) - 2025-01-31

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


SCHEDULE 13G



Comment for Type of Reporting Person:  Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.


SCHEDULE 13G


 
Malherbe Investments LLC
 
Signature:/s/ Stephen Malherbe
Name/Title:Sole Manager
Date:01/31/2025
 
Stephen Malherbe
 
Signature:/s/ Stephen Malherbe
Name/Title:Stephen Malherbe
Date:01/31/2025
primary_doc.xml